Literature DB >> 18405918

A unique mode of microtubule stabilization induced by peloruside A.

J Torin Huzil1, John K Chik, Gordon W Slysz, Holly Freedman, Jack Tuszynski, Richard E Taylor, Dan L Sackett, David C Schriemer.   

Abstract

Microtubules are significant therapeutic targets for the treatment of cancer, where suppression of microtubule dynamicity by drugs such as paclitaxel forms the basis of clinical efficacy. Peloruside A, a macrolide isolated from New Zealand marine sponge Mycale hentscheli, is a microtubule-stabilizing agent that synergizes with taxoid drugs through a unique site and is an attractive lead compound in the development of combination therapies. We report here unique allosteric properties of microtubule stabilization via peloruside A and present a structural model of the peloruside-binding site. Using a strategy involving comparative hydrogen-deuterium exchange mass spectrometry of different microtubule-stabilizing agents, we suggest that taxoid-site ligands epothilone A and docetaxel stabilize microtubules primarily through improved longitudinal interactions centered on the interdimer interface, with no observable contributions from lateral interactions between protofilaments. The mode by which peloruside A achieves microtubule stabilization also involves the interdimer interface, but includes contributions from the alpha/beta-tubulin intradimer interface and protofilament contacts, both in the form of destabilizations. Using data-directed molecular docking simulations, we propose that peloruside A binds within a pocket on the exterior of beta-tubulin at a previously unknown ligand site, rather than on alpha-tubulin as suggested in earlier studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18405918      PMCID: PMC2441936          DOI: 10.1016/j.jmb.2008.03.026

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  49 in total

1.  Hydrogen exchange/electrospray ionization mass spectrometry studies of structural features of proteins and protein/protein interactions.

Authors:  H Ehring
Journal:  Anal Biochem       Date:  1999-02-15       Impact factor: 3.365

2.  Conformations of laulimalide in DMSO-d6.

Authors:  Pahk Thepchatri; Daniel O Cicero; Edith Monteagudo; Arun K Ghosh; Ben Cornett; Eric R Weeks; James P Snyder
Journal:  J Am Chem Soc       Date:  2005-09-21       Impact factor: 15.419

3.  Total synthesis of (+)-peloruside A.

Authors:  Meizhong Jin; Richard E Taylor
Journal:  Org Lett       Date:  2005-03-31       Impact factor: 6.005

Review 4.  Understanding noncovalent interactions: ligand binding energy and catalytic efficiency from ligand-induced reductions in motion within receptors and enzymes.

Authors:  Dudley H Williams; Elaine Stephens; Dominic P O'Brien; Min Zhou
Journal:  Angew Chem Int Ed Engl       Date:  2004-12-10       Impact factor: 15.336

5.  Assembly of GMPCPP-bound tubulin into helical ribbons and tubes and effect of colchicine.

Authors:  Hong-Wei Wang; Sydney Long; K Rose Finley; Eva Nogales
Journal:  Cell Cycle       Date:  2005-09-20       Impact factor: 4.534

6.  The Amber biomolecular simulation programs.

Authors:  David A Case; Thomas E Cheatham; Tom Darden; Holger Gohlke; Ray Luo; Kenneth M Merz; Alexey Onufriev; Carlos Simmerling; Bing Wang; Robert J Woods
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

7.  Nucleotide-dependent bending flexibility of tubulin regulates microtubule assembly.

Authors:  Hong-Wei Wang; Eva Nogales
Journal:  Nature       Date:  2005-06-16       Impact factor: 49.962

8.  High-resolution model of the microtubule.

Authors:  E Nogales; M Whittaker; R A Milligan; K H Downing
Journal:  Cell       Date:  1999-01-08       Impact factor: 41.582

9.  Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity.

Authors:  Rubén M Buey; Isabel Barasoain; Evelyn Jackson; Arndt Meyer; Paraskevi Giannakakou; Ian Paterson; Susan Mooberry; José M Andreu; J Fernando Díaz
Journal:  Chem Biol       Date:  2005-12

10.  Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: a phase II trial.

Authors:  Ta-Chung Chao; Zyting Chu; Ling-Ming Tseng; Tzeon-Jye Chiou; Ruey-Kuen Hsieh; Wei-Shu Wang; Chueh-Chuan Yen; Muh-Hwa Yang; Liang-Tsai Hsiao; Jin-Hwang Liu; Po-Min Chen
Journal:  Invest New Drugs       Date:  2005-03       Impact factor: 3.850

View more
  40 in total

Review 1.  Microtubule targeting agents: from biophysics to proteomics.

Authors:  D Calligaris; P Verdier-Pinard; F Devred; C Villard; D Braguer; Daniel Lafitte
Journal:  Cell Mol Life Sci       Date:  2010-01-28       Impact factor: 9.261

2.  Nucleotide exchange in dimeric MCAK induces longitudinal and lateral stress at microtubule ends to support depolymerization.

Authors:  Kyle M Burns; Mike Wagenbach; Linda Wordeman; David C Schriemer
Journal:  Structure       Date:  2014-07-24       Impact factor: 5.006

3.  Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes.

Authors:  Arun Kanakkanthara; Anja Wilmes; Aurora O'Brate; Daniel Escuin; Ariane Chan; Ada Gjyrezi; Janet Crawford; Pisana Rawson; Bronwyn Kivell; Peter T Northcote; Ernest Hamel; Paraskevi Giannakakou; John H Miller
Journal:  Mol Cancer Ther       Date:  2011-06-08       Impact factor: 6.261

Review 4.  Conformation-activity relationships of polyketide natural products.

Authors:  Erik M Larsen; Matthew R Wilson; Richard E Taylor
Journal:  Nat Prod Rep       Date:  2015-08       Impact factor: 13.423

Review 5.  Peloruside, laulimalide, and noscapine interactions with beta-tubulin.

Authors:  Melissa M Gajewski; Laleh Alisaraie; Jack A Tuszynski
Journal:  Pharm Res       Date:  2012-06-26       Impact factor: 4.200

6.  Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.

Authors:  A L Risinger; J Li; M J Bennett; C C Rohena; J Peng; D C Schriemer; S L Mooberry
Journal:  Cancer Res       Date:  2013-09-18       Impact factor: 12.701

7.  Peloruside B, a potent antitumor macrolide from the New Zealand marine sponge Mycale hentscheli: isolation, structure, total synthesis, and bioactivity.

Authors:  A Jonathan Singh; Chun-Xiao Xu; Xiaoming Xu; Lyndon M West; Anja Wilmes; Ariane Chan; Ernest Hamel; John H Miller; Peter T Northcote; Arun K Ghosh
Journal:  J Org Chem       Date:  2010-01-01       Impact factor: 4.354

8.  Biological Characterization of an Improved Pyrrole-Based Colchicine Site Agent Identified through Structure-Based Design.

Authors:  Cristina C Rohena; Nakul S Telang; Chenxiao Da; April L Risinger; James A Sikorski; Glen E Kellogg; John T Gupton; Susan L Mooberry
Journal:  Mol Pharmacol       Date:  2015-12-11       Impact factor: 4.436

Review 9.  Microtubule-stabilizing drugs from marine sponges: focus on peloruside A and zampanolide.

Authors:  John H Miller; A Jonathan Singh; Peter T Northcote
Journal:  Mar Drugs       Date:  2010-03-31       Impact factor: 5.118

10.  Culture of explants from the sponge Mycale cecilia to obtain bioactive mycalazal-type metabolites.

Authors:  Jose L Carballo; Benjamin Yañez; Eva Zubía; Maria J Ortega; Cristina Vega
Journal:  Mar Biotechnol (NY)       Date:  2009-11-26       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.